Buy Rating on Context Therapeutics's CTIM-76 Bolstered by Market Validation and Competitive Edge
TipRanksApr 11 13:15 ET
Buy Rating Justified by Advances in T Cell Engagers and Context Therapeutics' Strategic Drug Positioning
TipRanksMar 22 13:55 ET
Context Therapeutics' Promising Financial and Preclinical Results Bolster Buy Rating: A Focus on CTIM-76's High Potency and Target Specificity
TipRanksNov 11, 2023 07:06 ET
Promising Potential of CTIM-76 Drug: A Comprehensive Buy Rating Analysis for Context Therapeutics
TipRanksNov 10, 2023 06:47 ET
HC Wainwright & Co. Upgrades Context Therapeutics to Buy, Announces $5 Price Target
BenzingaNov 1, 2023 07:17 ET
Context Therapeutics Analyst Ratings
BenzingaNov 1, 2023 07:16 ET
Analysts Are Bullish on These Healthcare Stocks: AstraZeneca (AZN), Context Therapeutics (CNTX)
TipRanksOct 24, 2023 15:10 ET
H.C. Wainwright Remains a Hold on Context Therapeutics (CNTX)
TipRanksOct 24, 2023 06:18 ET
Context Therapeutics Analyst Ratings
BenzingaSep 11, 2023 08:24 ET
H.C. Wainwright Downgrades Context Therapeutics (CNTX) to a Hold
TipRanksMar 23, 2023 06:21 ET
Context Therapeutics Analyst Ratings
Benzinga Analyst RatingsFeb 7, 2023 06:21 ET
HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $4 Price Target
Benzinga Real-time NewsFeb 7, 2023 06:21 ET
Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Context Therapeutics (CNTX)
TipRanksFeb 7, 2023 06:21 ET
H.C. Wainwright Sticks to Their Buy Rating for Context Therapeutics (CNTX)
TipRanksDec 8, 2022 13:05 ET
Context Therapeutics (CNTX) Receives a Buy From H.C. Wainwright
TipRanksDec 2, 2022 07:05 ET
H.C. Wainwright Remains a Buy on Context Therapeutics (CNTX)
TipRanksNov 10, 2022 06:35 ET
H.C. Wainwright Sticks to Their Buy Rating for Context Therapeutics (CNTX)
TipRanksSep 27, 2022 12:06 ET
H.C. Wainwright Reaffirms Their Buy Rating on Context Therapeutics (CNTX)
TipRanksAug 12, 2022 06:30 ET
Watching Context Therapeutics; Edison Group Issues $9.46 Price Target
Benzinga Real-time NewsAug 2, 2022 09:50 ET
No Data
No Data